A recent study compared the clinical outcomes of postoperative adjuvant radiotherapy versus early-salvage radiotherapy administered to patients with stage pT3 prostate cancer or those with positive margins.

News

By Scott Baltic

NEW YORK (Reuters Health) - In patients with prostate adenocarcinoma, postdiagnosis statin use was associated with reduced mortality both from prostate cancer (PC) and from all causes, according to a nationwide registry study from Denmark.

Read More

Older age is associated with a lesser chance of receiving definitive therapy and a higher chance of receiving primary androgen deprivation therapy in patients with intermediate-risk or high-risk prostate cancer, according to research published in Cancer (online August 22, 2017; doi:10.1002/cncr.30948).

Read More

Research in Review

Adjuvant radiation therapy may be more effective at treating prostate cancer than no treatment or salvage radiation therapy, according to a recent study published in BJU International.

Read More

While survival at 10 years is similar, localized prostate cancer may be more likely to metastasize in men receiving active surveillance compared with those who have surgery or radiation therapy, according to results from a clinical trial published in the New England Journal of Medicine.

Read More

Despite recent advances in understanding prostate cancer heterogeneity, better methods for classification of prostate cancer are still needed. Researchers at Cedars-Sinai have developed a new method to identify which patients with prostate cancer will develop aggressive types of disease even if their tumors at first appear to be lower risk.

Read More

A larger number of docetaxel cycles may improve survival among men with metastatic castration-resistant prostate cancer (mCRPC), according to a post-hoc analysis of phase III clinical trial results.

Read More

Subscribe to Prostate Cancer